Avenues of communication between the brain and tissues/organs involved in energy homeostasis

Endocrine Journal

Volumn 54, Issue 4, 2007, Pages 497-505

  Yamada, Tetsuya ^a,b   Katagiri, Hideki ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; AMINO ACID; FATTY ACID; GLUCOSE; HUMORAL ANTIBODY; LEPTIN;

AUTONOMIC NERVOUS SYSTEM; BRAIN TISSUE; EFFECTOR CELL; EFFERENT NERVE; ENERGY; FOOD INTAKE; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; METABOLISM; NUTRIENT; OBESITY; REVIEW;

ADIPOSE TISSUE; ANIMALS; BRAIN; DIGESTIVE SYSTEM; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; LIVER; PANCREAS; VAGUS NERVE;

EID: 34548685323     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.KR-106     Document Type: Review

References (65)

1. Flier JS (2004) Obesity wars: molecular progress confronts an expanding epidemic. Cell 116: 337-350.
2. Miller JC, Gnaedinger JM, Rapoport SI (1987) Utilization of plasma fatty acid in rat brain: distribution of [14C]palmitate between oxidative and synthetic pathways. J Neurochem 49: 1507-1514.
3. Rapoport SI (1996) In vivo labeling of brain phospholipids by long-chain fatty acids: relation to turnover and function. Lipids 31 (Suppl): S97-101.
4. Wang R, et al. (2006) Effects of oleic acid on distinct populations of neurons in the hypothalamic arcuate nucleus are dependent on extracellular glucose levels. J Neurophysiol 95: 1491-1498.
5. Obici S, et al. (2002) Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51: 271-275.
6. Obici S, et al. (2003) Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 9: 756-761.
7. Pocai A, et al. (2005) A brain-liver circuit regulates glucose homeostasis. Cell Metab 1: 53-61.
8. Hu Z, et al. (2003) Hypothalamic malonyl-CoA as a mediator of feeding behavior. Proc Natl Acad Sci USA 100: 12624-12629.
9. Minokoshi Y, et al. (2004) AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428: 569-574.
10. Andersson U, et al. (2004) AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 279: 12005-12008.
11. Choi YH, Fletcher PJ, Anderson GH (2001) Extracellular amino acid profiles in the paraventricular nucleus of the rat hypothalamus are influenced by diet composition. Brain Res 892: 320-328.
12. Cota D, et al. (2006) Hypothalamic mTOR signaling regulates food intake. Science 312: 927-930.
13. Meijer AJ, Dubbelhuis PF (2004) Amino acid signalling and the integration of metabolism. Biochem Biophys Res Commun 313: 397-403.
14. Proud CG (2002) Regulation of mammalian translation factors by nutrients. Eur J Biochem 269: 5338-5349.
15. Levin BE, et al. (2004) Neuronal glucosensing: what do we know after 50 years? Diabetes 53: 2521-2528.
16. Arluison M, et al. (2004) Distribution and anatomical localization of the glucose transporter 2 (GLUT2) in the adult rat brain- an immunohistochemical study. J Chem Neuroanat 28: 117-136.
17. Arluison M, et al. (2004) Immunocytochemical localization of the glucose transporter 2 (GLUT2) in the adult rat brain. II. Electron microscopic study. J Chem Neuroanat 28: 137-146.
18. Sutherland VL, et al. (2005) Developmental expression of glucokinase in rat hypothalamus. Brain Res Dev Brain Res 154: 255-258.
19. Alvarez E, et al. (2005) The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem. J Neurochem 92: 798-806.
20. Kang L, et al. (2004) Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes 53: 549-559.
21. Wang R, et al. (2004) The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 53: 1959-1965.
22. Prodi E, Obici S (2006) Minireview: the brain as a molecular target for diabetic therapy. Endocrinology 147: 2664-2669.
23. Plum L, Belgardt BF, Bruning JC (2006) Central insulin action in energy and glucose homeostasis. J Clin Invest 116: 1761-1766.
24. Pocai A, et al. (2005) Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434: 1026-1031.
25. Inoue H, et al. (2006) Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab 3: 267-275.
26. Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395: 763-770.
27. Bates SH, Myers MG (2004) The role of leptin - STAT3 signaling in neuroendocrine function: an integrative perspective. J Mol Med 82: 12-20.
28. Bjorbaek C, et al. (1997) Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 272: 32686-32695.
29. Niswender KD, et al. (2001) Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 413: 794-795.
30. Qi Y, et al. (2004) Adiponectin acts in the brain to decrease body weight. Nat Med 10: 524-529.
31. Badman MK, Flier JS (2005) The gut and energy balance: visceral allies in the obesity wars. Science 307: 1909-1914.
32. Shimazu T (1981) Central nervous system regulation of liver and adipose tissue metabolism. Diabetologia 20 (Suppl): 343-356.
33. Bartness TJ, Bamshad M (1998) Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am J Physiol 275 (5 Pt 2): R1399-1411.
34. Imai J, et al. (2006) Cold exposure suppresses serum adiponectin levels through sympathetic nerve activation in mice. Obesity (Silver Spring) 14: 1132-1141.
35. Kreier F, et al. (2002) Selective parasympathetic innervation of subcutaneous and intra-abdominal fat - functional implications. J Clin Invest 110: 1243-1250.
36. Niijima A (1998) Afferent signals from leptin sensors in the white adipose tissue of the epididymis, and their reflex effect in the rat. J Auton Nerv Syst 73: 19-25.
37. Tanida M, et al. (2000) Leptin injection into white adipose tissue elevates renal sympathetic nerve activity dose-dependently through the afferent nerves pathway in rats. Neurosci Lett 293: 107-110.
38. Kreier F, et al. (2006) Tracing from fat tissue, liver, and pancreas: a neuroanatomical framework for the role of the brain in type 2 diabetes. Endocrinology 147: 1140-1147.
39. Yamada T, et al. (2006) Signals from intra-abdominal fat modulate insulin and leptin sensitivity through different mechanisms: neuronal involvement in food-intake regulation. Cell Metab 3: 223-229.
40. Thorens B, Larsen PJ (2004) Gut-derived signaling molecules and vagal afferents in the control of glucose and energy homeostasis. Curr Opin Clin Nutr Metab Care 7: 471-478.
41. Strader AD, Woods SC (2005) Gastrointestinal hormones and food intake. Gastroenterology 128: 175-191.
42. Havel PJ (2001) Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med (Maywood) 226: 963-977.
43. Kojima M, Kangawa K (2005) Ghrelin: structure and function. Physiol Rev 85: 495-522.
44. Smith GP, et al. (1981) Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 213: 1036-1037.
45. Koda S, et al. (2005) The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 146: 2369-2375.
46. Abbott CR, et al. (2005) The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 1044: 127-131.
47. Date Y, et al. (2002) The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123: 1120-1128.
48. Reimann F, Gribble FM (2002) Glucose-sensing in glucagon-like peptide-1-secreting cells. Diabetes 51: 2757-2763.
49. Gribble FM, et al. (2003) A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 52: 1147-1154.
50. Kojima M, et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660.
51. Adachi A, et al. (1984) Convergence of hepatoportal glucose-sensitive afferent signals to glucose-sensitive units within the nucleus of the solitary tract. Neurosci Lett 46: 215-218.
52. Niijima A (1984) Reflex control of the autonomic nervous system activity from the glucose sensors in the liver in normal and midpontine-transected animals. J Auton Nerv Syst 10: 279-285.
53. Burcelin R, Dolci W, Thorens B (2000) Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice. Diabetes 49: 1643-1648.
54. Hevener AL, Bergman RN, Donovan CM (1997) Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes 46: 1521-1525.
55. Burcelin R, et al. (2001) Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor. Diabetes 50: 1720-1728.
56. Nakabayashi H, et al. (1996) Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am J Physiol 271 (5 Pt 1): E808-813.
57. Ionut V, et al. (2005) Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones. Diabetologia 48: 967-975.
58. Donovan CM, Halter JB, Bergman RN (1991) Importance of hepatic glucoreceptors in sympathoadrenal response to hypoglycemia. Diabetes 40: 155-158.
59. Fujita S, Donovan CM (2005) Celiac-superior mesenteric ganglionectomy, but not vagotomy, suppresses the sympathoadrenal response to insulin-induced hypoglycemia. Diabetes 54: 3258-3264.
60. Ishigaki Y, et al. (2005) Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity. Diabetes 54: 322-332.
61. Matsusue K, et al. (2005) Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 111: 737-747.
62. Rahimian R, et al. (2001) Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Mol Cell Biochem 224: 29-37.
63. Chao L, et al. (2000) Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest 106: 1221-1228.
64. Uno K, et al. (2006) Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 312: 1656-1659.
65. Lam TK, Schwartz GJ, Rossetti L (2005) Hypothalamic sensing of fatty acids. Nat Neurosci 8: 579-584.